| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.9M | +414.5% |
| Cost of Revenue | $2.4M | +929.7% |
| R&D Expense | $17.1M | +80.2% |
| SG&A Expense | $36.9M | +172.4% |
| Operating Income | -$65.5M | -54.5% |
| Pre-tax Income | -$40.1M | +72.2% |
| Income Tax | -$28K | -153.8% |
| Net Income | -$40.1M | +72.3% |
| EPS (Basic) | -$0.40 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $8.2M | — |
| Accounts Receivable | $2.2M | +24.6% |
| Current Assets | $61.2M | -42.5% |
| Total Assets | $123.8M | -9.5% |
| Current Liabilities | $8.9M | +33.0% |
| Total Liabilities | $19.9M | -46.0% |
| Stockholders' Equity | $100.0M | +0.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.1M | +22.6% |
| Capital Expenditures | $3.0M | +190.0% |
| Investing Cash Flow | -$15.7M | -1127.5% |
| Financing Cash Flow | $43K | -100.0% |
| Free Cash Flow | -$40.1M | +18.2% |
| +94.1% |
| EPS (Diluted) | -$0.40 | +94.1% |